Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

210 questions in 21 reviews · Lung Cancer

current versions
No studies 15 · 7.1%Ungraded 2 · 1%Very low 15 · 7.1%Low 66 · 31.4%Moderate 50 · 23.8%High 62 · 29.5%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Annual low‐dose CT screening vs annual chest x‐ray
Lung cancer mortality · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.8 [0.7, 0.92]1 study · 53454 participantsHigh
Annual low‐dose CT screening vs annual chest x‐ray
All‐cause mortality · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.94 [0.88, 1]1 study · 53454 participantsHigh
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening
Lung cancer mortality ‐ Annual chest x‐ray plus 4‐monthly cytology versus annual x‐ray alone · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.88 [0.74, 1.03]2 studies · 20427 participantsHigh
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening
All‐cause mortality ‐ More frequent chest x‐ray screening versus less frequent screening · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 1.01 [0.94, 1.08]4 studies · 170149 participantsLow
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening
All‐cause mortality ‐ Annual chest x‐ray plus 4‐monthly cytology versus annual x‐ray alone · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 1.03 [0.91, 1.15]1 study · 10040 participantsHigh
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening
Lung cancer 5‐year survival ‐ More frequent chest x‐ray screening versus less frequent screening · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.91 [0.84, 0.99]4 studies · 1775 participantsLow
Lung cancer screening with chest radiography +/‐ sputum cytology vs less intense screening
Lung cancer 5‐year survival ‐ Annual chest x‐ray plus 4‐monthly cytology versus annual x‐ray alone · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.83 [0.75, 0.92]1 study · 837 participantsModerate
Annual chest x‐ray screening vs usual care (no regular screening)
Lung cancer mortality at 6 years of · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.91 [0.81, 1.03]1 study · 154901 participantsHigh
Annual chest x‐ray screening vs usual care (no regular screening)
Lung cancer mortality at 13 years of · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.99 [0.91, 1.07]1 study · 154901 participantsHigh
Annual chest x‐ray screening vs usual care (no regular screening)
Deaths from all causes (excluding deaths from PLCO cancers) · Patients with lung cancer
Screening for lung cancer (2013) · Cochrane
RR 0.98 [0.96, 1.01]1 study · 154901 participantsHigh